(Q34534675)

2 August 2017

1 reference

title

Endothelin-1 and atherosclerosis: potential complications associated with endothelin-receptor blockade (English)

1 reference

2 August 2017

1 reference

Michael R Dashwood

1

1 reference

PubMed ID

11849651

2 August 2017

Janice C S Tsui

series ordinal

2

1 reference

PubMed ID

11849651

2 August 2017

language of work or name

1 reference

1 February 2002

1 reference

2 August 2017

1 reference

2 August 2017

160

1 reference

2 August 2017

2

1 reference

2 August 2017

297-304

1 reference

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

The pathogenesis of atherosclerosis: a perspective for the 1990s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Neovascularization and coronary atherosclerotic plaque: cinematographic localization and quantitative histologic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Adventitial remodeling after coronary arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Rupture of coronary vasa vasorum as a trigger of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

The role of plaque rupture and thrombosis in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Molecular biology and biochemistry of the endothelins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Effects of endothelins on collagen turnover in cardiac fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Endothelin-1 increases intracellular calcium in human monocytes and causes production of interleukin-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Endothelin-1 enhances vascular cell adhesion molecule-1 expression in tumor necrosis factor alpha-stimulated vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Endotoxin and pro-inflammatory cytokines stimulate endothelin-1 expression and release by airway epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Elevated endothelin levels in patients with hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Increased endothelin plasma concentrations in patients with coronary artery disease or hyperlipoproteinemia without coronary events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Increased plasma levels of endothelin in diabetic patients with hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Elevated endothelin-1 levels after cigarette smoking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Endothelin-1 is increased overlying atherosclerotic plaques in human arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

The effect of the ETA receptor antagonist, FR 139317, on [125I]‐ET‐1 binding to the atherosclerotic human coronary artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

[125I]-PD151242: a selective radioligand for human ETA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Increased immunoreactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions. A possible role in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Endothelin alters the reactivity of vasa vasorum: mechanisms and implications for conduit vessel physiology and pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

[125I]-endothelin-1 binding to vasa vasorum and regions of neovascularization in human and porcine blood vessels: a possible role for endothelin in intimal hyperplasia and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Endothelin-1 and endothelin receptors in porcine saphenous vein-carotid artery grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Distribution of endothelin-1 (ET) receptors (ET(A) and ET(B)) and immunoreactive ET-1 in porcine saphenous vein-carotid artery interposition grafts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Endothelin receptors in cultured adult rat cardiac fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Endothelins: effect on matrix biosynthesis and proliferation in normal and scleroderma fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

The intima. Soil for atherosclerosis and restenosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Altered endothelin-1 binding following balloon angioplasty of pig coronary arteries: effect of the ETA receptor antagonist, LU 135252

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Effect of endothelin-1 infusion on the development of intimal hyperplasia after balloon catheter injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Role of microvascular endothelial cells in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Endothelins are angiogenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

7 January 2021

Endothelin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Endothelins in health and disease: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Endothelin: role in experimental hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Clearance of circulating endothelin-1 by ETB receptors in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Is vascular smooth muscle cell proliferation beneficial?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

Role of endothelin-1 in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Autoradiographic localization of [125I]endothelin binding sites in human blood vessels and coronary tissue: functional correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900586-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(01)00586-X

1 reference

2 August 2017

1 reference

PubMed ID

11849651